What does the National Prescribing Service have to say about it all? CEO Dr Lynn Weekes writes:
“Advertising of medicines, like much advertising, is moving to digital media and social networks.
Bisolvon cough and cold products are not suitable for children under two years of age. Indeed the evidence for effectiveness of the active ingredient, bromhexine, for coughs and colds is weak overall.
This campaign highlights the importance of adverse effects and harms being given equal prominence with effectiveness.
There should be easy to find information that highlights unsuitability for young children. This information is provided on the company’s website if you drill down into FAQs.
NPS would like to see this safety information given more prominence.”